Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21162432 | 0.86 | FOLH1 (0.30) | — | |
| SCHEMBL21162733 | 0.84 | CA2 (0.35) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL19487471 | 0.84 | CA2 (0.38) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL3880967 | 0.79 | THRB (0.34) | TSHRTDP1 | |
| SCHEMBL25777211 | 0.77 | CHRM1 (0.48) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL24704082 | 0.76 | — | — | |
| SCHEMBL26345841 | 0.73 | CA2 (0.37) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL22644859 | 0.70 | CA2 (0.39) | CA2MAPK1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL21162715 | 0.68 | CA2 (0.31) | CA2MAPK1 | |
| SCHEMBL24263709 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250118-A1 | ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-08-10 | — | — | US | disclosed |
| US-20230240129-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-07-27 | — | — | US | disclosed |
| US-11581498-B2 | Organic luminescent material containing 6-silyl-substituted isoquinoline ligand | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-02-14 | — | — | US | disclosed |
| US-20220389041-A1 | LIGHT-EMITTING MATERIAL WITH A POLYCYCLIC LIGAND | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-12-08 | — | — | US | disclosed |
| US-20220393115-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220389041-A1 | LIGHT-EMITTING MATERIAL WITH A POLYCYCLIC LIGAND | CRY1, LEF1, CYBA | CA2 3015/4885MAPK1 1090/4885SLC1A3 2061/4885 |
| US-20230250118-A1 | ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | CRY1, LEF1, PIEZO1 | CA2 3367/4885MAPK1 265/4885SLC1A3 2957/4885 |
| US-20220393115-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | LEF1, L1CAM, PIEZO1 | CA2 2303/4885MAPK1 400/4885SLC1A3 2900/4885 |
| US-11581498-B2 | Organic luminescent material containing 6-silyl-substituted isoquinoline ligand | EML4, ILK, CCNL2 | CA2 3105/4885MAPK1 3156/4885SLC1A3 3162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.